Generic drugmakers tout competition bill as pressure builds to tackle drug costs

Generic drugmakers tout competition bill as pressure builds to tackle drug costs-modernhealthcare: The generic drug industry, responding to public anger over big price hikes for some generic products, is calling for action on a bipartisan Senate bill it says would increase the number of cheaper generic drugs and reduce U.S. drug spending.